Translating Discovery to Companion Diagnostics for Antibody-Drug Conjugates Through AI-Driven Image Analysis
Time: 9:30 am
day: Conference Day One
Details:
- Digital pathology offers exciting opportunities for novel biomarker discovery, development, and clinical diagnostics
- Efficacy of antibody-drug conjugates may depend on target antigen expression or other histopathologic features that can be developed as a predictive signature
- Drug developers are eager to identify digital pathology solutions to optimally support pipelines and patient identification